ÌìÃÀÓ°Ôº

Summary: Late-stage scaling of spray drying for inhaled formulations can result in avoidable delays, post-approval issues, and cost overruns.

Bringing complex oral drugs to the clinic requires overcoming significant solubility, permeability, and bioavailability challenges.

Summary: Pharmaceutical innovators face growing pressure to overcome solubility, permeability, and bioavailability challenges, especially for complex, poorly soluble molecules.

Summary: Early clinical trials are becoming more complex as sponsors face rising regulatory requirements and the challenges of developing advanced drug candidates.

Summary:​ The pharmaceutical industry faces mounting pressure to deliver consistent, high-quality products whilst managing escalating costs and regulatory demands.

Summary: Stick packs are valued for their compact size, ease of use, and portability, offering unique advantages for improving patient adherence and treatment experiences.

Early-phase trials are often delayed by rigid manufacturing models, fixed-dose formats, and limited API availability.

Formulating Beyond Rule of Five (bRo5) molecules presents significant bioavailability and development challenges, especially for small or emerging pharma with limited API and constrained budgets.

Summary: Pregastric absorption has emerged as a critical pathway to achieve these goals by enabling drugs to bypass gastrointestinal degradation and first-pass metabolism.

Summary: Inhalation powders have been used for decades to treat lung diseases and conditions requiring rapid systemic therapy.